162 related articles for article (PubMed ID: 9278752)
1. Treatment outcome for 424 primary cases of clinical I cutaneous malignant melanoma of the head and neck.
Kane WJ; Yugueros P; Clay RP; Woods JE
Head Neck; 1997 Sep; 19(6):457-65. PubMed ID: 9278752
[TBL] [Abstract][Full Text] [Related]
2. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
4. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
7. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
Shen P; Guenther JM; Wanek LA; Morton DL
Ann Surg Oncol; 2000 Mar; 7(2):114-9. PubMed ID: 10761789
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
10. [Management of lymph nodes in head and neck melanoma: a retrospective study of 25 cases].
Ricard AS; Majoufre-Lefebvre C; Delaunay M; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):505-8. PubMed ID: 17900640
[TBL] [Abstract][Full Text] [Related]
11. Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study Group.
Hansson J; Ringborg U; Lagerlöf B; Afzelius LE; Augustsson I; Blomquist E; Boeryd B; Carlin E; Edström S; Eldh J
Melanoma Res; 1994 Dec; 4(6):407-11. PubMed ID: 7703722
[TBL] [Abstract][Full Text] [Related]
12. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
13. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
15. [Elective lymph node dissection in primary malignant melanoma].
Petres J; Rompel R; Büttner P; Teichelmann K; Garbe C
Hautarzt; 1996 Jan; 47(1):29-34. PubMed ID: 8835001
[TBL] [Abstract][Full Text] [Related]
16. Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience.
Jaber JJ; Clark JI; Muzaffar K; Ruggiero FP; Feustel PJ; Frett MJ; Zender CA
Head Neck; 2011 Jan; 33(1):7-12. PubMed ID: 20848424
[TBL] [Abstract][Full Text] [Related]
17. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
18. Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.
Andersson AP; Gottlieb J; Drzewiecki KT; Hou-Jensen K; Sondergaard K
Cancer; 1992 Mar; 69(5):1153-6. PubMed ID: 1739914
[TBL] [Abstract][Full Text] [Related]
19. Significance of clinical stage, extent of surgery and outcome in cutaneous squamous cell carcinoma of the head and neck.
Košec A; Svetina L; Lukšić I
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):82-8. PubMed ID: 23137734
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]